vs
Side-by-side financial comparison of FutureFuel Corp. (FF) and JOINT Corp (JYNT). Click either name above to swap in a different company.
FutureFuel Corp. is the larger business by last-quarter revenue ($19.8M vs $15.2M, roughly 1.3× JOINT Corp). JOINT Corp runs the higher net margin — 6.5% vs -60.5%, a 67.1% gap on every dollar of revenue. On growth, JOINT Corp posted the faster year-over-year revenue change (3.1% vs -67.7%). JOINT Corp produced more free cash flow last quarter ($334.7K vs $-29.9M). Over the past eight quarters, JOINT Corp's revenue compounded faster (-28.6% CAGR vs -41.7%).
FutureFuel Corporation is a developer and producer of chemicals and biofuels. It is listed on the New York Stock Exchange, with symbol FF.
The Joint Corp is a leading operator and franchisor of chiropractic care clinics primarily serving the U.S. market. It offers accessible, affordable routine chiropractic services, membership-based care plans, and caters to consumers seeking non-invasive musculoskeletal pain management and wellness support.
FF vs JYNT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $19.8M | $15.2M |
| Net Profit | $-12.0M | $991.1K |
| Gross Margin | -46.7% | 81.4% |
| Operating Margin | -62.9% | 4.9% |
| Net Margin | -60.5% | 6.5% |
| Revenue YoY | -67.7% | 3.1% |
| Net Profit YoY | -529.4% | 5510.5% |
| EPS (diluted) | $-0.28 | $0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $19.8M | $15.2M | ||
| Q3 25 | $22.7M | $13.4M | ||
| Q2 25 | $35.7M | $13.3M | ||
| Q1 25 | $17.5M | $13.1M | ||
| Q4 24 | $61.5M | $14.7M | ||
| Q3 24 | $51.1M | $30.2M | ||
| Q2 24 | $72.4M | $30.3M | ||
| Q1 24 | $58.3M | $29.7M |
| Q4 25 | $-12.0M | $991.1K | ||
| Q3 25 | $-9.3M | $855.0K | ||
| Q2 25 | $-10.4M | $93.4K | ||
| Q1 25 | $-17.6M | $967.8K | ||
| Q4 24 | $2.8M | $17.7K | ||
| Q3 24 | $-1.2M | $-3.2M | ||
| Q2 24 | $9.6M | $-3.6M | ||
| Q1 24 | $4.3M | $947.0K |
| Q4 25 | -46.7% | 81.4% | ||
| Q3 25 | -30.1% | 80.1% | ||
| Q2 25 | -24.6% | 79.1% | ||
| Q1 25 | -83.0% | 77.3% | ||
| Q4 24 | 9.1% | 78.4% | ||
| Q3 24 | 0.7% | 90.7% | ||
| Q2 24 | 12.0% | 90.7% | ||
| Q1 24 | 8.6% | 90.9% |
| Q4 25 | -62.9% | 4.9% | ||
| Q3 25 | -42.9% | 1.2% | ||
| Q2 25 | -33.4% | -8.6% | ||
| Q1 25 | -107.4% | -5.2% | ||
| Q4 24 | 2.6% | 5.5% | ||
| Q3 24 | -5.6% | -1.6% | ||
| Q2 24 | 7.5% | -5.9% | ||
| Q1 24 | 3.8% | -1.4% |
| Q4 25 | -60.5% | 6.5% | ||
| Q3 25 | -41.1% | 6.4% | ||
| Q2 25 | -29.2% | 0.7% | ||
| Q1 25 | -100.6% | 7.4% | ||
| Q4 24 | 4.5% | 0.1% | ||
| Q3 24 | -2.3% | -10.5% | ||
| Q2 24 | 13.2% | -11.9% | ||
| Q1 24 | 7.4% | 3.2% |
| Q4 25 | $-0.28 | $0.06 | ||
| Q3 25 | $-0.21 | $0.06 | ||
| Q2 25 | $-0.24 | $0.01 | ||
| Q1 25 | $-0.40 | $0.06 | ||
| Q4 24 | $0.06 | $0.01 | ||
| Q3 24 | $-0.03 | $-0.21 | ||
| Q2 24 | $0.22 | $-0.24 | ||
| Q1 24 | $0.10 | $0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $51.3M | $23.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $154.7M | $15.1M |
| Total Assets | $192.2M | $61.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $51.3M | $23.6M | ||
| Q3 25 | $85.6M | $29.7M | ||
| Q2 25 | $95.2M | $29.8M | ||
| Q1 25 | $97.1M | $21.9M | ||
| Q4 24 | $109.5M | $25.1M | ||
| Q3 24 | $133.4M | $20.7M | ||
| Q2 24 | $115.1M | $17.5M | ||
| Q1 24 | $201.1M | $18.7M |
| Q4 25 | $154.7M | $15.1M | ||
| Q3 25 | $169.1M | $22.7M | ||
| Q2 25 | $178.2M | $23.2M | ||
| Q1 25 | $188.4M | $22.8M | ||
| Q4 24 | $205.8M | $20.7M | ||
| Q3 24 | $213.3M | $20.5M | ||
| Q2 24 | $214.4M | $23.2M | ||
| Q1 24 | $204.8M | $26.2M |
| Q4 25 | $192.2M | $61.0M | ||
| Q3 25 | $203.5M | $69.4M | ||
| Q2 25 | $218.2M | $73.2M | ||
| Q1 25 | $227.7M | $80.1M | ||
| Q4 24 | $247.7M | $83.2M | ||
| Q3 24 | $256.5M | $79.6M | ||
| Q2 24 | $261.2M | $82.4M | ||
| Q1 24 | $365.4M | $85.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-27.4M | $1.8M |
| Free Cash FlowOCF − Capex | $-29.9M | $334.7K |
| FCF MarginFCF / Revenue | -150.5% | 2.2% |
| Capex IntensityCapex / Revenue | 12.2% | 9.9% |
| Cash ConversionOCF / Net Profit | — | 1.86× |
| TTM Free Cash FlowTrailing 4 quarters | $-46.0M | $-1.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-27.4M | $1.8M | ||
| Q3 25 | $-1.1M | $1.8M | ||
| Q2 25 | $5.2M | $868.6K | ||
| Q1 25 | $-5.4M | $-3.7M | ||
| Q4 24 | $-16.6M | $9.4M | ||
| Q3 24 | $25.8M | $3.4M | ||
| Q2 24 | $27.8M | $-973.5K | ||
| Q1 24 | $-12.2M | $2.8M |
| Q4 25 | $-29.9M | $334.7K | ||
| Q3 25 | $-6.5M | $1.5M | ||
| Q2 25 | $-263.0K | $363.6K | ||
| Q1 25 | $-9.4M | $-4.0M | ||
| Q4 24 | $-20.7M | $8.2M | ||
| Q3 24 | $20.5M | $3.2M | ||
| Q2 24 | $24.8M | $-1.2M | ||
| Q1 24 | $-14.5M | $2.4M |
| Q4 25 | -150.5% | 2.2% | ||
| Q3 25 | -28.5% | 10.9% | ||
| Q2 25 | -0.7% | 2.7% | ||
| Q1 25 | -53.6% | -30.8% | ||
| Q4 24 | -33.6% | 55.9% | ||
| Q3 24 | 40.1% | 10.6% | ||
| Q2 24 | 34.3% | -4.1% | ||
| Q1 24 | -24.9% | 8.1% |
| Q4 25 | 12.2% | 9.9% | ||
| Q3 25 | 23.5% | 2.4% | ||
| Q2 25 | 15.3% | 3.8% | ||
| Q1 25 | 22.8% | 2.5% | ||
| Q4 24 | 6.6% | 8.1% | ||
| Q3 24 | 10.4% | 0.8% | ||
| Q2 24 | 4.1% | 0.9% | ||
| Q1 24 | 3.9% | 1.3% |
| Q4 25 | — | 1.86× | ||
| Q3 25 | — | 2.07× | ||
| Q2 25 | — | 9.30× | ||
| Q1 25 | — | -3.82× | ||
| Q4 24 | -5.94× | 532.98× | ||
| Q3 24 | — | — | ||
| Q2 24 | 2.90× | — | ||
| Q1 24 | -2.82× | 2.97× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FF
| Chemicals | $18.0M | 91% |
| Biofuels | $1.8M | 9% |
JYNT
| Transferred At Point In Time | $12.8M | 84% |
| Transferred Over Time | $2.4M | 16% |
